Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

Agrawal, U; Bedston, S; McCowan, C; Oke, J; Patterson, L; Robertson, C; Akbari, A; Azcoaga-Lorenzo, A; Bradley, DT; Fagbamigbe, AF; Grange, Z; Hall, ECR; Joy, M; Katikireddi, SV; Kerr, S; Ritchie, L; Murphy, S; Owen, RK; Rudan, I; Shah, SA; Simpson, CR; Torabi, F; Tsang, RSM; de Lusignan, S; Lyons, RA; O'Reilly, D; Sheikh, A

Journal article

Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

Abstract:: Background
Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. In response to an urgent request from the UK Joint Committee on Vaccination and Immunisation, we aimed to identify risk factors for severe COVID-19 outcomes (ie, COVID-19-related hospitalisation or death) in individuals who had completed their primary... Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Agrawal, U., Bedston, S., McCowan, C., Oke, J., Patterson, L., Robertson, C., Akbari, A., Azcoaga-Lorenzo, A., Bradley, D. T., Fagbamigbe, A. F., Grange, Z., Hall, E. C. R., Joy, M., Katikireddi, S. V., Kerr, S., Ritchie, L., Murphy, S., Owen, R. K., Rudan, I., … Sheikh, A. (2022). Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet, 400(10360), 1305–1320.

MLA Style

Agrawal, U., et al. “Severe COVID-19 Outcomes after Full Vaccination of Primary Schedule and Initial Boosters: Pooled Analysis of National Prospective Cohort Studies of 30 Million Individuals in England, Northern Ireland, Scotland, and Wales.” Lancet, vol. 400, no. 10360, Elsevier, 2022, pp. 1305–20.

Chicago Style

Agrawal, U, S Bedston, C McCowan, J Oke, L Patterson, C Robertson, A Akbari, et al. 2022. “Severe COVID-19 Outcomes after Full Vaccination of Primary Schedule and Initial Boosters: Pooled Analysis of National Prospective Cohort Studies of 30 Million Individuals in England, Northern Ireland, Scotland, and Wales.” Lancet 400 (10360): 1305–20.
Share
Print